Patents Assigned to Erasca, Inc.
  • Antibodies against EGFR and their uses
    Patent number: 12760111
    Abstract: Described herein are antibodies that bind EGFR domain II and/or Domain III. Also described are bispecific antibodies that bind domain II and domain II of EGFR. Also described are methods and uses for treating cancer.
    Type: Grant
    Filed: June 24, 2022
    Date of Patent: October 13, 2026
    Assignee: ERASCA, INC.
    Inventors: Sachdev Sidhu, Jarrett Adams, Max London, Dewald Van Dyk
  • Tricyclic pyridones and pyrimidones
    Patent number: 12162893
    Abstract: A compound of Formula (I) is provided: where the variables are defined herein.
    Type: Grant
    Filed: September 22, 2021
    Date of Patent: December 10, 2024
    Assignee: ERASCA, INC.
    Inventors: Jun Feng, Jean-Michel Vernier, Marcos Gonzalez-Lopez, Benjamin Jones, Nicholas A. Isley, Ping Chen
  • Tricyclic pyridones and pyrimidones
    Patent number: 11845761
    Abstract: Compounds with KRAS G12C inhibitory active are disclosed and methods of using the same to treat a cancer comprising a K-Ras G12C mutation.
    Type: Grant
    Filed: December 8, 2022
    Date of Patent: December 19, 2023
    Assignee: Erasca, Inc.
    Inventors: Jun Feng, Jean-Michel Vernier, Marcos Gonzalez-Lopez, Benjamin Jones, Nicholas A. Isley, Ping Chen